ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 94 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122 | -42.7% | 22,947 | +2.8% | 0.00% | – |
| Q2 2023 | $213 | -2.3% | 22,325 | +13.0% | 0.00% | – |
| Q1 2023 | $218 | -23.5% | 19,765 | +2.7% | 0.00% | – |
| Q4 2022 | $285 | -100.0% | 19,246 | -89.3% | 0.00% | -100.0% |
| Q3 2022 | $3,427,000 | -64.5% | 179,294 | -60.4% | 0.00% | 0.0% |
| Q2 2022 | $9,655,000 | +11.7% | 453,057 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $8,642,000 | -49.4% | 448,702 | -45.5% | 0.00% | -50.0% |
| Q4 2021 | $17,073,000 | -12.2% | 823,168 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $19,439,000 | -23.0% | 813,694 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $25,242,000 | +32.9% | 924,958 | +40.9% | 0.00% | 0.0% |
| Q1 2021 | $18,990,000 | +156.9% | 656,421 | +149.8% | 0.00% | +100.0% |
| Q4 2020 | $7,392,000 | -74.5% | 262,781 | -73.5% | 0.00% | -66.7% |
| Q3 2020 | $29,037,000 | -10.0% | 991,021 | -7.1% | 0.00% | -25.0% |
| Q2 2020 | $32,252,000 | +10.4% | 1,066,540 | +8.8% | 0.00% | -20.0% |
| Q1 2020 | $29,222,000 | – | 980,614 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $165,956,000 | 12.78% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $57,330,000 | 6.84% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,874,000 | 3.97% |
| Logos Global Management LP | 1,525,000 | $29,143,000 | 3.58% |
| 1492 Capital Management LLC | 178,320 | $3,408,000 | 2.45% |
| Cormorant Asset Management, LP | 1,000,000 | $19,110,000 | 1.34% |
| MPM BioImpact LLC | 257,185 | $4,915,000 | 1.16% |
| Orbimed Advisors | 2,800,000 | $53,508,000 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 220,985 | $4,223,000 | 0.83% |
| Rubric Capital Management LP | 472,047 | $9,021,000 | 0.45% |